RecruitingPhase 2NCT05969275

Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock

Studying Antisynthetase syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ottawa Hospital Research Institute
Principal Investigator
Lauralyn McIntyre, MD
Ottawa Hospital Research Institute
Intervention
Allogeneic umbilical cord-derived human mesenchymal stromal cells(biological)
Enrollment
296 enrolled
Eligibility
18 years · All sexes
Timeline
20242027

Study locations (2)

Collaborators

Canadian Institutes of Health Research (CIHR) · Stem Cell Network · Canadian Critical Care Trials Group · Technische Universität Dresden

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05969275 on ClinicalTrials.gov

Other trials for Antisynthetase syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antisynthetase syndrome

← Back to all trials